
|Articles|August 19, 2014
- Immunotherapy (Issue 3)
- Volume 3
- Issue 1
The Management of Side Effects Associated With Immunotherapies
Author(s)Jedd D. Wolchok, MD, PhD
Jedd D. Wolchok, MD, PhD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the management of side effects associated with immunotherapies.
Advertisement
Jedd D. Wolchok, MD, PhD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the management of side effects associated with immunotherapies.
View more about managing side effects and the limitations of immunotherapies > >
Articles in this issue
almost 12 years ago
A Brief History of Immunotherapyalmost 12 years ago
Better Biomarker Testing Needed in Immuno-Oncologyalmost 12 years ago
Autoimmunity and Limitations of Cancer Vaccinesalmost 12 years ago
Combining Immunotherapies With Targeted Therapies and Other Immunotherapiesalmost 12 years ago
The Next Wave in Immunotherapy: Combinationsalmost 12 years ago
Future Immune Checkpoint StrategiesAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma
2
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
3
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
4
FDA Grants Priority Review to Giredestrant for ER+/HER2- Breast Cancer
5


































